Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07625033 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Risk Factors of Atrial Fibrillation After Cardiac Surgery

Study acronym: PFAS
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 25, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jun 1, 2026 to Jul 1, 2026
    • Primary and study completion pushed from Jun 1, 2026 to Jul 1, 2026
    • Site details revised
    v3
  2. Study sites: 0 to 1
    • Study title shortened, about 4 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Supraventricular arrhythmias complicate more than 40% of cardiac surgeries and are associated with an increased risk of bleeding, stroke, heart failure, and death. Preventing the occurrence of these arrhythmias is a major challenge. This study aims to investigate risk factors and protective factors regarding atrial fibrillation and other iatrogenic cardiac arrhythmias after cardiac surgery, particularly innovative anesthetic strategies such as stellar ganglion blockade which have been recently implemented in our center.
Trial Details
NCT Number NCT07625033
Lead Sponsor Centre Hospitalier Régional Metz-Thionville
Conditions
(from sponsor)		 Cardiac Surgery, Peri Operative Medicine, Thoracic Surgery, Cardiopulmonary Bypass, Coronary Artery Bypass, Heart Valve Prosthesis Implantation, Aortic Valve Replacement, Perioperative Medicine +7 more
Related terms Simpson-Golabi-Behmel syndrome
Enrollment 918 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov